Inovio Pharmaceuticals, Inc.
INO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $37 | $24 | $40 | $66 |
| Short-Term Investments | $14 | $23 | $28 | $28 |
| Receivables | $1 | $1 | $1 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $3 | $4 | $2 | $3 |
| Total Curr. Assets | $55 | $53 | $72 | $98 |
| Property Plant & Equip (Net) | $10 | $10 | $11 | $12 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $2 | $3 | $2 | $2 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $2 | $2 | $2 |
| Total NC Assets | $14 | $16 | $15 | $15 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $69 | $68 | $87 | $113 |
| Liabilities | – | – | – | – |
| Payables | $6 | $5 | $6 | $6 |
| Short-Term Debt | $3 | $3 | $3 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $61 | $24 | $19 | $26 |
| Total Curr. Liab. | $70 | $32 | $27 | $35 |
| LT Debt | $7 | $8 | $9 | $9 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $7 | $8 | $9 | $9 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $7 | $11 | $11 | $12 |
| Total Liabilities | $77 | $40 | $36 | $45 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,819 | -$1,773 | -$1,750 | -$1,730 |
| AOCI | -$1 | -$1 | -$1 | -$1 |
| Other Equity | $1,812 | $1,803 | $1,802 | $1,799 |
| Total Equity | -$8 | $29 | $51 | $69 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $69 | $68 | $87 | $113 |
| Net Debt | -$27 | -$14 | -$29 | -$54 |